Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06116136
What this trial is testing

Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

Who this might be right for
MSI-H/dMMR Gastroesophageal-junction CancerMSI-H/dMMR Gastric Cancer
Servier Bio-Innovation LLC 48
Early research (Phase 1)UnknownNCT06329206
What this trial is testing

A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Genhouse Bio Co., Ltd. 156
Large-scale testing (Phase 3)Study completedNCT01012258
What this trial is testing

Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Merck KGaA, Darmstadt, Germany 70
Testing effectiveness (Phase 2)Looking for participantsNCT05827796
What this trial is testing

IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
InxMed (Shanghai) Co., Ltd. 70
Early research (Phase 1)Looking for participantsNCT06792552
What this trial is testing

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube Cancer+5 more
NextCure, Inc. 738
Testing effectiveness (Phase 2)Study completedNCT03744468
What this trial is testing

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-inHNSCC for Phase 2 Dose ExpansionNSCLC for Phase 2 Dose Expansion
BeiGene 147
Early research (Phase 1)Study completedNCT03736850
What this trial is testing

Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
CStone Pharmaceuticals 17
Early research (Phase 1)UnknownNCT05200273
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114

Who this might be right for
Advanced or Metastatic Solid TumorsMalignancyMetastasis
Akeso 30
Early research (Phase 1)Looking for participantsNCT06589596
What this trial is testing

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 525
Early research (Phase 1)Ended earlyNCT04887259
What this trial is testing

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple MyelomaAcute Myeloid Leukemia
Lava Therapeutics 16
Early research (Phase 1)WithdrawnNCT04974996
What this trial is testing

Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8)

Who this might be right for
Diffuse Large B-Cell Lymphoma
ADC Therapeutics S.A.
Early research (Phase 1)Looking for participantsNCT07618260
What this trial is testing

SIM0613 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 294
Early research (Phase 1)Study completedNCT02407990
What this trial is testing

Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors

Who this might be right for
Advanced Cancer
BeiGene 451
Testing effectiveness (Phase 2)UnknownNCT05257512
What this trial is testing

Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shouyao Holdings (Beijing) Co. LTD 150
Early research (Phase 1)Study completedNCT04972981
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ADC Therapeutics S.A. 30
Early research (Phase 1)Looking for participantsNCT06752681
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Day One Biopharmaceuticals, Inc. 300
Early research (Phase 1)Ended earlyNCT01826448
What this trial is testing

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

Who this might be right for
V600-mutated BRAF Unresectable MelanomaV600-mutated BRAF Metastatic MelanomaStage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor
Daiichi Sankyo 13
Early research (Phase 1)Looking for participantsNCT06598800
What this trial is testing

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 153
Early research (Phase 1)Ended earlyNCT02464007
What this trial is testing

Study of rSIFN-co for Patients With Advanced Solid Tumors

Who this might be right for
Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor
Sichuan Huiyang Life Science and Technology Corporation 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04734262
What this trial is testing

A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

Who this might be right for
Metastatic Breast Cancer
Fudan University 98
Next Page